Works matching IS 10685308 AND DT 2022 AND VI 33 AND IP 4
1
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 9, doi. 10.1002/pu.30836
- Article
2
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 8, doi. 10.1002/pu.30861
- Article
3
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 8, doi. 10.1002/pu.30860
- Article
4
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 8, doi. 10.1002/pu.30859
- Article
5
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 7, doi. 10.1002/pu.30858
- Article
6
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 7, doi. 10.1002/pu.30857
- Article
7
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 7, doi. 10.1002/pu.30856
- Article
8
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 6, doi. 10.1002/pu.30855
- Article
9
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 6, doi. 10.1002/pu.30854
- Article
10
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 4, doi. 10.1002/pu.30853
- Article
11
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 2, doi. 10.1002/pu.30851
- Article
12
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 1, doi. 10.1002/pu.30850
- Article
13
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 1, doi. 10.1002/pu.30849
- Article
14
- Brown University Psychopharmacology Update, 2022, v. 33, n. 4, p. 3, doi. 10.1002/pu.30852
- Article